chr11-77243806-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182833.3(GDPD4):c.1129G>T(p.Val377Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182833.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDPD4 | NM_182833.3 | c.1129G>T | p.Val377Leu | missense_variant | Exon 13 of 17 | ENST00000315938.5 | NP_878253.1 | |
GDPD4 | XM_011544834.1 | c.1207G>T | p.Val403Leu | missense_variant | Exon 13 of 18 | XP_011543136.1 | ||
GDPD4 | XM_047426557.1 | c.795+1475G>T | intron_variant | Intron 10 of 12 | XP_047282513.1 | |||
GDPD4 | XM_047426558.1 | c.795+1475G>T | intron_variant | Intron 10 of 12 | XP_047282514.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDPD4 | ENST00000315938.5 | c.1129G>T | p.Val377Leu | missense_variant | Exon 13 of 17 | 1 | NM_182833.3 | ENSP00000320815.4 | ||
GDPD4 | ENST00000376217.6 | c.1129G>T | p.Val377Leu | missense_variant | Exon 12 of 17 | 1 | ENSP00000365390.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461530Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727106
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1129G>T (p.V377L) alteration is located in exon 12 (coding exon 11) of the GDPD4 gene. This alteration results from a G to T substitution at nucleotide position 1129, causing the valine (V) at amino acid position 377 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at